Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
We recently reviewed elsewhere the vast array of therapeutic opportunities that the targeting of each one of these receptors offers, not only as a hope for the future, but as a current success, as several MC drugs have already been approved and many others are in clinical phase of development (135)
In primary care, pitfalls include treating presumed infection with antibiotics, or assuming a lesion is a wart, skin tag or patch of eczema and prescribing topical steroids
At Ally Vascular & Pain Centers, we provide Prostate Artery Embolization (PAE), a minimally invasive treatment for an enlarged prostate that helps you regain normal urinary function without the risks of traditional surgery
